Subjects

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

• #PJMindTheGap Lead

• Abortifacient agents

• Academia

• Acute kidney injury

• Addiction

• Adherence compliance and concordance

• Advanced pharmacy framework

• Advanced practice

• Adverse drug reaction, side effects and toxicity

• Africa

• Alcohol deterrents

• Alcoholism

• All-Wales Medicines Strategy Group

• Allied health professions

• Anaesthesia

• Anaesthesia adjuvants

• Analgesics

• Animal diseases

• Animal experimentation

• Anthropology

• Anti-allergic agents

• Anti-arrhythmia agents

• Anti-asthmatic agents

• Anti-dyskinesia agents

• Anti-infective agents

• Anti-inflammatory agents

• Anti-obesity agents

• Anti-ulcer agents

• Antibacterial agents (antibiotics)

• Anticoagulants

• Anticoagulation

• Anticonvulsants

• Antidiarrheals

• Antiemetics

• Antifungal agents

• Antihypertensive agents

• Antimicrobial resistance

• Antimicrobial stewardship

• Antimicrobial stewardship- Faculty

• Antineoplastic agents

• Antiparasitic agents

• Antipsychotics

• Antirheumatic agents

• Antisickling agents

• Antitussive agents

• Antiviral agents

• Art

• Aseptic dispensing

• Asia

• Assisted dying

• Association of Independent Multiple Pharmacies

• Asthma

• Atrial fibrillation

• Audit

• Australia

• Awards

• Bacterial infections

• Biological targeting

• Biology

• Bioprinting

• Biosimilar pharmaceuticals

• Blood substitutes

• Board elections

• Breast cancer

• Bronchoconstrictor agents

• Budget Setting and Reimbursement

• Business and management

• Business planning

• Buying groups

• C. Competences for pharmacists working in community practice

• C1. Working with patients and the public to maximise the efficacy, safety and cost-effectiveness of medicines

• C1a. Assessing the medication needs of patients

• C1b. Reviewing medication for its clinical appropriateness

• C1c. Reviewing medication with patients to identify difficulties and potential risk, eg concordance issues, adverse effects, changing medication needs

• C1d. Monitoring indicators of disease progress, drug efficacy or drug toxicity

• C1e. Providing a pharmaceutical service to patients in their home

• C1f. Providing advice and counselling, eg related to minor ailments, medicines for purchase, appliances, self-care

• C1g. Participating in referral schemes to treat minor ailments

• C1h. Undertaking clinical audit

• C1i. Generating and maintaining records of medication supplied to patients

• C1j. Recording and reporting adverse drug reactions

• C1k. Documenting pharmaceutical care plans

• C1l. Producing and providing practice leaflets containing information about services available

• C2. Working with patients and the public to promote health

• C2a. Providing information to promote public health and prevent disease

• C2b. Participating in national and local health campaigns and initiatives

• C2c. Creating and making use of opportunities to encourage healthy lifestyles

• C2d. Providing a smoking cessation service

• C2e. Screening and testing for chronic conditions

• C2f. Providing advice in relation to self-testing

• C3. Addressing the health and medication needs of specific client groups

• C3a. Addressing the medication needs of patients transferring from one health/social care setting to another

• C3b. Providing pharmaceutical care to the elderly and their carers

• C3c. Providing pharmaceutical care to children and their carers

• C3d. Providing pharmaceutical care to patients who require palliative care in their own homes

• C3e. Providing pharmaceutical care to people with chronic conditions, eg asthma, diabetes, CHD, mental ill health

• C3f. Providing pharmaceutical care to people with specific dietary needs

• C3g. Providing services to drug misusers, including supervised administration and needle exchange

• C3h. Providing pharmaceutical care to people who use surgical appliances, hosiery and medical gases

• C4. Working with other professions in healthcare and with other sectors

• C4a. Acting on referrals from GPs and NHS Direct

• C4b. Providing medicines-related information to other healthcare professionals

• C4c. Providing training and education to other healthcare professionals

• C4d. Evaluating drug information to assist other professionals

• C4e. Participating in the development and review of patient group directions, treatment protocols, formularies and guidelines

• C4f. Evaluating and reviewing medicines use and utilisation

• C4g. Working across professional boundaries

• C4h. Providing training and education to pharmacy staff

• C4i. Analysing and reviewing repeat prescribing

• C4j. Providing a pharmaceutical service to care homes, including intermediate care, and to hospices

• C4k. Signposting to other healthcare or social care provision

• C5. Working according to the NHS contract

• C5a. Understanding, and working in accordance with, NHS terms of service and contract, including specifications of the Drug Tariff

• C5b. Analysing and evaluating prescribing data

• C5c. Developing and implementing new services under local or national contracts

• C5d. Participating in local accreditation schemes

• C5e. Providing services out of hours

• C5f. Premises design for dispensing and consulting services

• C6. Supplying medicines, dressings and appliances; and managing stock

• C6a. Dispensing / managing the dispensing process

• C6b. Providing a repeat dispensing service

• C6c. Providing collection and delivery services

• C6d. Providing an emergency hormonal contraception service

• C6e. Supplying oxygen

• C6f. Managing stock, including correct storage

• C6g. Disposing of medication and participating in medication disposal schemes

• C7. Working in a business context

• C7a. Analyse basic business problems, assess alternative choices, and propose actions

• C7b. Present, summarise, interpret and analyse economic and business data

• C7c. Buying and selling

• C7d. Marketing services and products to identified customer groups

• C7e. Premises design to meet business needs

• Calcium channel blockers

• Canada

• Cancer

• Cancer care

• Cancer drugs funding

• Capsules

• Cardioplegic solutions

• Cardiotonic agents

• Cardiovascular agents

• Cardiovascular diseases

• Care homes and intermediate care

• Care of older people

• Care Quality Commission (CQC)

• Career

• Career stages

• Case control study

• Case report

• Cathartics

• Cell biology

• Cell therapy

• Central America

• Central muscle relaxants

• Central nervous system agents

• Central nervous system depressants

• Central nervous system stimulants

• Channel Islands

• Charities

• Chelation therapy

• Chemoprevention

• Chemotherapy

• Chief pharmacist

• Cholagogues and choleretics

• Chronic kidney disease

• Chronic medication services

• Chronic obstructive pulmonary disease (COPD)

• Chronic pain management

• Climate change

• Clinical commissioning groups

• Clinical governance

• Clinical pharmacist

• Clinical pharmacology

• Clinical pharmacy

• Clinical prioritisation

• Clinical protocols

• Clinical research

• CLUSTER 1. Expert Professional Practice

• CLUSTER 1. Patient and Pharmaceutical Care

• CLUSTER 2. Collaborative Working Relationships

• CLUSTER 2. Professional Practice Competencies

• CLUSTER 3. Leadership

• CLUSTER 3. Personal Practice Competencies

• CLUSTER 4: Management - Faculty

• CLUSTER 4: Management and Organisation

• CLUSTER 5. Education, Training and Development

• CLUSTER 6. Research and Evaluation - Faculty

• Coagulants

• Cognitive behavioural therapy

• Cohort study

• College of Mental Health Pharmacy

• Colloids

• Combination products

• Commissioning support units

• Common and minor ailment services

• Commonwealth of Independent States

• CommunicateAction

• Communication and information management

• Communication skills

• Community pharmacy

• Community Pharmacy England

• Community Pharmacy Scotland

• Community pharmacy services

• Community Pharmacy Wales

• Company Chemists' Association

• Competency areas

• Complementary and alternative medicines

• Compound management

• Conferences and meetings

• Confidentiality and privacy

• Congenital, hereditary, and neonatal diseases and abnormalities

• Consultant pharmacist

• Consumer advocacy

• Continuing professional development (CPD)

• Contraceptive agents

• Controlled Drugs

• Counterfeit medicines

• Creams

• Creutzfeldt–Jakob disease - CJD

• Critical appraisal

• Critical care

• Critical care- Faculty

• Crohn's disease

• Curricula

• CV writing

• Cytochrome P450

• Degenerative neurological disorders

• Dementia

• Dentistry

• Department of Health (England)

• Depression

• Dermatologic agents

• Dermatological conditions

• Diabetes

• Diagnosis

• Diagnostic errors

• Diagnostic techniques and procedures

• DiagnosticProcedure

• Diagnostics and biomarkers

• Dialysis solutions

• Differential diagnosis

• Digestive system diseases

• Digestive system signs and symptoms

• Discontinued products

• Disinfectants

• Disorders of environmental origin

• Dispensing

• Distance education

• Dosage forms

• Drops

• Drug

• Drug abuse

• Drug classes

• Drug design

• Drug development funding

• Drug discovery and development

• Drug dosage calculations

• Drug implants

• Drug information services

• Drug interactions

• Drug labelling

• Drug legal status

• Drug manufacturing

• Drug packaging

• Drug pricing

• Drug repositioning

• Drug resistance

• Drug stability

• Drug storage

• Drug substitution

• Drug switching

• Drug-drug interactions

• Drug-food interactions

• Drug-herb interactions

• DrugClass

• DrugLegalStatus

• Drugs used in erectile dysfunction

• Drugs used in prostatic hyperplaesia

• Drugs used in urinary incontinence

• Ear, Nose and Throat diseases

• Early years/foundation level

• Economics

• Eczema

• Education and training

• Education and Training - Foundation

• Educational organisations

• Educational technology

• Effective communication

• Effective Communication Skills

• Electronic prescribing

• Emetics

• Employment

• Employment terms and conditions

• Endocrine system diseases

• England

• England NHS structures

• Enteric-coated preparations

• Environmental design

• Environmental science

• Epidemiologic studies

• Equality and discrimination

• Ethics and bioethics

• Ethnicity

• Europe

• European Medicines Agency (EMA)

• European Union

• Evaluation of Outcomes

• Event

• Evidence-based medicine

• Expectorants

• Eye diseases

• Feasibility studies

• Fertility agents

• Fibrinolytic agents

• Fitness to practise

• Follow up

• Formulation

• Fungal infections

• G. General competences for pharmacists

• G1. Being a pharmacist

• G10. Ensuring health and safety

• G10a. Complying with health and safety legislation

• G10b. Adopting safe working practices

• G10c. Accepting shared responsibility for the safety of the working environment

• G1a. Using expert knowledge and skills to benefit patients

• G1b. Using expert knowledge and skills to assist other healthcare professionals

• G1c. Giving informed and accurate pharmaceutical advice

• G1d. Taking a patient-centred approach

• G1e. Making sound decisions and solving problems in relation to drug therapy

• G1f. Using clinical and pharmaceutical knowledge to optimise the balance among effectiveness, safety and cost of medicines

• G1g. Working within professional and organisational standards

• G1h. Complying with pharmacy legislation, ethics and regulatory body policies

• G1i. Working within boundaries of own professional expertise

• G1j. Applying knowledge of the NHS and working according to NHS systems

• G1k. Taking responsibility for the delivery of a pharmacy service to patients

• G1l. Acting with professional autonomy

• G1m. Keeping abreast of issues affecting pharmacy and pharmacists

• G1n. Maintaining awareness of political, economic and managerial aspects of healthcare

• G1o. Implementing national priorities

• G1p. Implementing and supporting policy on health education

• G1q. Promoting health and healthy lifestyles

• G1r. Sourcing and providing good quality medicinal products

• G1s. Recognising the contribution of, and collaborating with, other healthcare professionals

• G1t. Working across professional and organisational boundaries

• G1u. Working with sectors other than healthcare

• G1v. Signposting to other services

• G1w. Taking on new roles or responsibilities

• G2. Interacting, and working with, people

• G2a. Demonstrating inter-personal skills, irrespective of the situation or the other person/people involved

• G2b. Demonstrating presentation skills

• G2c. Taking account of special communication needs in some circumstances

• G2d. Recognising barriers to communication

• G2e. Being assertive

• G2f. Treating all people with respect

• G2g. Leading teams and engendering common purpose

• G2h. Working to develop and maintain team relationships (pharmacy and inter-professional)

• G2i. Positively influencing individuals and organisations

• G2j. Negotiating effectively

• G2k. Minimising and resolving conflict

• G2l. Being supportive and motivational

• G2m. Maintaining and protecting privacy and confidentiality

• G2n. Utilising the skills and knowledge of others

• G2o. Responding to requests for advice or information

• G3. Being personally effective

• G3a. Taking responsibility for own actions

• G3b. Reflecting on own performance and taking responsibility for self-development

• G3c. Recognising own limitations and referring to others when appropriate

• G3d. Working with confidence

• G3e. Being flexible

• G3f. Being self-motivated and self-reliant

• G3g. Setting and achieving personal and professional objectives

• G3h. Thinking broadly and outside traditional boundaries

• G3i. Being organised

• G3j. Managing time and prioritising

• G3k. Managing workload

• G3l. Coping with pressure and stress

• G3m. Being reliable

• G3n. Showing initiative

• G3o. Showing innovation

• G3p. Showing, or sharing, vision

• G4. Being a manager

• G4a. Showing reasoning and judgement to manage situations

• G4b. Managing physical resources* [* see G2 and G6 for aspects of managing people]

• G4c. Managing finances

• G4d. Managing projects and activities

• G4e. Managing and facilitating change

• G4f. Overcoming obstacles in a changing environment

• G4g. Seeing opportunities for change and development

• G4h. Planning own work

• G4i. Planning work activities for a team

• G4j. Delegating appropriately

• G4k. Facilitating and encouraging the use of skill mix

• G4l. Planning strategically

• G4m. Recruiting and selecting staff

• G4n. Succession and contingency planning

• G5. Upholding quality and continuous improvement

• G5a. Participating in professional audit G5b

• G5d. Developing standards of practice, protocols and operating procedures

• G5e. Adopting a reflective approach to practice

• G5f. Complying with non-pharmacy legislation related to own sphere of practice, eg laws related to data protection, employment, discrimination

• G5g. Implementing, or contributing to, the clinical governance agenda

• G5h. Identifying and managing risk

• G5i. Applying the principles of quality assurance to own practice

• G5j. Challenging current practice

• G5k. Responding to complaints

• G6. Helping others to learn and develop

• G6a. Supporting and advising others in their development

• G6b. Developing effective learning environments and learner support systems

• G6c. Helping others to take responsibility for their own learning

• G6d. Setting objectives and planning with learners

• G6e. Contributing to the design and planning of learning activities

• G6f. Teaching or training

• G6g. Creating and using coaching opportunities

• G6h. Supervising others

• G6i. Taking account of learners’ needs and learning styles

• G6j. Using learning technologies appropriate to the context of the teaching/training

• G6k. Monitoring and evaluating own teaching/training

• G6l. Being a positive role model

• G6m. Being a mentor

• G6n. Facilitating others’ CPD

• G6o. Linking education/training with practice

• G6p. Providing learners with opportunities to demonstrate their skills and knowledge

• G6q. Promoting self-appraisal

• G6r. Assessing others’ knowledge

• G6s. Assessing others’ performance

• G6t. Providing constructive feedback

• G6u. Reviewing others’ progress

• G7. Making decisions and solving problems

• G7a. Identifying the exact nature of a problem

• G7b. Identify key information and options to resolve the problem

• G7c. Using suitable approaches to resolve specific problems

• G7d. Making sound decisions after analysing information and options

• G7e. Following up to ensure a problem is resolved

• G8. Working with information

• G8a. Obtaining relevant and up-to-date information

• G8b. Using a variety of information sources

• G8c. Recognising when an information source is not suitable or reliable

• G8d. Using a variety of information retrieval techniques

• G8e. Evaluating information to identify key points and discard irrelevant and poor information

• G8f. Applying evaluated information to practice

• G8g. Sharing information

• G8h. Ensuring the quality of information provided

• G8i. Recording data and information so that retrieval of key material is easily possible

• G8j. Manipulating data to extract key information

• G8k. Taking account of the limitations of information technology

• G8l. Using information technology

• G9. Participating in research and development

• G9a. Demonstrating critical evaluation skills

• G9b. Identifying gaps in the evidence base

• G9c. Identifying research needs in the workplace

• G9d. Generating or creating evidence

• G9e. Developing and evaluating research protocols

• G9f. Applying research evidence in practice G9g

• G9i. Developing the service

• G9j. Participating in the development of healthcare policy

• Gain share

• Gastrointestinal agents

• Gathering Information

• Gels

• Gender

• Gene therapy

• General Medical Council

• General Pharmaceutical Council (GPhC)

• General sales list medicines

• Generic medicines

• Genetics

• Geriatric medicine

• Global health

• Government

• GovernmentOrganization

• GP

• GPhC Competency areas

• Grants and funding

• Great Britain

• Guild of Healthcare Pharmacists

• Haematinics

• Haematologic agents

• Haematology

• Haemic and lymphatic diseases

• Hallucinogens

• Health and care policy

• Health communication and promotion

• Health Education and Improvement Wales

• Health Education England

• Health inequalities

• Health literacy

• Health services administration

• Health technology assessors

• Healthcare informatics

• Healthcare provision

• Healthy living pharmacy

• Heart failure

• Heart health

• Hepatitis B

• Hepatitis C

• History

• HIV

• HIV Pharmacy Association

• HIV- Faculty

• Homecare

• Homeopathy

• Hospital doctor

• Hospital pharmacy

• HP. Competences for pharmacists working in hospital practice

• HP1. Planning pharmaceutical care for individual patients

• HP10. Promoting quality and improving practice

• HP10a. Contributing to the clinical governance agenda

• HP10b. Managing risk

• HP10c. Managing/embracing change

• HP10d. Utilising the skills of other staff (skill mix)

• HP10e. Training and developing staff

• HP10f. Adopting reflective practice

• HP10g. Recognising responsibility and accountability HP10h

• HP10l. Participating in clinical audit HP10m

• HP10o. Undertaking performance review of staff

• HP10p. Reducing medication errors

• HP10q. Learning from errors

• HP10r. Contributing to the development of quality standards

• HP11. Managing formularies, guidelines and protocols

• HP11a. Developing formularies, guidelines and protocols in liaison with medical staff, nursing staff and other pharmacy colleagues

• HP11b. Ensuring that stocks of medicines held in treatment areas conform to the formulary

• HP11c. Ensuring that procedures are in place for the supply of formulary and non-formulary items

• HP11d. Reviewing formularies, guidelines and protocols in collaboration with medical, nursing and pharmacy staff

• HP11e. Ensuring that deviation from a formulary, clinical guideline or treatment protocol is the result of an active decision which involves the pharmacist

• HP12. Working across professional and organisational boundaries

• HP12a. Working/liaising with primary care

• HP12b. Providing support to prescribers, eg reviewing repeat prescribing

• HP12c. Using and contributing to shared records

• HP12d. Providing intermediate care services

• HP12e. Providing palliative care services, eg to hospices

• HP12f. Developing joint care protocols

• HP12g. Working with NHS agencies

• HP12h. Working with sectors other than healthcare

• HP13 . Reviewing and developing services

• HP13a. Reviewing services

• HP13b. Developing new services

• HP13c. Developing ‘whole system’ prescribing

• HP13d. Redesigning processes

• HP13e. Redesigning medicines supply, eg original pack dispensing, automation

• HP13f. Improving procurement systems

• HP14. Producing, using and maintaining records; using information technology

• HP14a. Using information technology, eg electronic records

• HP14b. Compiling information on patients’ current and past drug treatments

• HP14c. Documenting a medication history/profile HP14d

• HP15. Undertaking specialised activities

• HP15a. Supplementary prescribing (see separate competences for supplementary prescribers)

• HP15b. Participating in, or running, outpatient clinics

• HP15c. Producing aseptic and cytotoxic products in a specialised unit

• HP15d. Preparing sterile and non-sterile products extemporaneously in a licensed production unit

• HP15e. Managing an aseptic or production unit

• HP15f. Working in, or running, a quality assurance service

• HP15g. Preparing products for clinical trials

• HP15h. Preparing radiopharmaceuticals

• HP1a. Assessing the individual patient’s pharmaceutical needs

• HP1b. Conducting a structured patient interview

• HP1c. Compiling a medication history/medication profile

• HP1d. Taking account of the patient’s medication history/profile and clinical records

• HP1e. Taking account of risk factors (w.r.t. the patient and the medication)

• HP1f. Liaising with other members of the patient’s healthcare team

• HP1g. Selecting, or advising on, suitable medication, dose, route, frequency, timing and duration

• HP1h. Monitoring the patient’s progress and outcomes

• HP1i. Reviewing, monitoring and updating the pharmaceutical care plan

• HP1j. Recording the pharmaceutical care plan and the advice given to the patient and members of the healthcare team

• HP2. Providing medicines information and advice

• HP2a. Keeping up-to-date with new products and therapeutic advances

• HP2b. Anticipating and identifying the need for evaluated drug information to support formulary review or individual patient care

• HP2c. Establishing the background to requests for drug information and advice from healthcare professionals and patients

• HP2d. Participating in the education and training of other healthcare professionals

• HP2e. Advising on the legal and ethical considerations of using medicines in ways which are not covered by a product licence

• HP2f. Liaising with others in regard to clinical trials in progress in the ward or unit

• HP2g. Providing advice on pharmaceutical aspects of clinical trial design, eg to research and ethical committees

• HP3. Promoting the safety, efficacy and cost-effectiveness of medicines

• HP3a. Reviewing prescribing

• HP3b. Reviewing patients’ medication, eg on admission

• HP3c. Educating and training other healthcare professionals on the safe and effective use of medicines

• HP3d. Training, advising and counselling patients and carers in medicines taking

• HP3e. Educating groups, eg patient groups, school children

• HP3f. Providing information leaflets and other written information

• HP3g. Assessing and prioritising the education and counselling needs of patients

• HP3h. Monitoring patients’ understanding of information provided

• HP3i. Recording education and counselling activities

• HP3j. Training other healthcare staff to provide education and counselling on the use of medicines and appliances

• HP3k. Involving patients and carers in the audit of education and counselling services

• HP3l. Assessing future medicines cost pressures

• HP4. Monitoring prescriptions

• HP5. Identifying and managing risk to patients

• HP5a. Ensuring that prescribing for individual patients takes account of predictable adverse effects

• HP5b. Ensuring that unnecessary drug use is avoided

• HP5c. Individualising drug dosage requirements

• HP5d. Identifying risk factors specific to the patient, eg their characteristics; social, environmental, functional, cognitive; aspects of their disease

• HP5e. Identifying risk factors in relation to the patient’s medication, eg toxicity, availability, bio-availability, administration issues

• HP5f. Ensuring that patients receive cautionary and advisory labels and appropriate counselling in relation to the use of their medication

• HP5g. Identifying patients who will require close monitoring of their medicines administration

• HP5h. Educating and training pharmacy staff and other healthcare staff on the prevention, detection and reporting of ADRs

• HP5i. Monitoring patients for adverse reactions, including delayed effects

• HP5j. Participating in therapeutic drug monitoring

• HP5k. Using all sources of information that may be helpful in detecting and monitoring ADRs

• HP5l. Reporting, and encouraging others to report, ADRs

• HP5m. Monitoring patients for iatrogenic disease

• HP6. Optimising medicines administration

• HP6a. Ensuring medication is administered correctly

• HP6b. Developing/managing self-administration schemes

• HP6c. Training staff involved in the administration of medicines

• HP7. Promoting health

• HP7a. Providing health education information

• HP7b. Promoting healthy lifestyles and increasing awareness of current issues and guidelines

• HP7c. Screening for chronic conditions

• HP7d. Planning and managing vaccination and immunisation programmes

• HP7e. Participating in measures to minimise the spread of communicable diseases, eg in relation to travellers, sexual practices, drug misuse

• HP7f. Contributing to health protection initiatives

• HP8. Evaluating medicines use

• HP8a. Identifying medicines which are suitable for medicines use evaluation

• HP8b. Defining acceptable standards for medicines use, with objective and measurable criteria

• HP8c. Measuring and documenting outcomes against the standards HP8d

• HP9. Managing transfer to another healthcare setting

• HP9a. Collaborating with professionals to whom responsibility for the patient is to be transferred

• HP9b. Taking account of shared care protocols

• HP9c. Ensuring the patient receives appropriate counselling and advice on discharge

• HP9d. Writing/reviewing the discharge prescription

• HP9e. Reviewing the pharmaceutical care plan for the patient

• HP9f. Making arrangements for the necessary medicines, dressings and appliances to be supplied on time

• HP9g. Documenting the discharge/transfer and pharmaceutical care plans

• HP9h. Transferring information between the healthcare settings

• Human rights

• Hygiene

• Hypersensitivity and allergy

• Hypertension

• Identifying and solving problems

• Identifying problems

• Immune system diseases

• Immunology

• Immunotherapy

• Independent multiple

• Independent pharmacy

• Independent Pharmacy Federation

• Independent prescribing

• India

• Individual funding requests

• Individualised medicine

• Infectious diseases

• inflammatory bowel disease

• Influenza (Flu)

• Inhalers and nebulised solutions

• Injections and infusions

• Insurance

• Intellectual property rights

• International and intergovernmental organisations

• International Pharmaceutical Federation (FIP)

• Internet pharmacy

• Interventional studies

• Intravenous fluids

• Investigational medicines

• Job interview

• Kidney diseases - Renal disorders

• Knowledge

• Laboratory automation

• Laboratory techniques

• Labour unions

• Law

• Laxatives

• Leadership

• Learning outcomes

• Learning topics

• Life sciences

• Lifestyle and fitness

• Lipid-regulating drugs

• Lipotropic agents

• Literature

• Liver diseases

• Local health boards (Wales)

• Local practice forums

• Locally agreed services

• Locations

• Locum pharmacist

• Luteolytic agents

• Management

• Management skills

• Media

• Medical conditions

• Medical indigency

• Medical profession

• MedicalEnumeration

• Medication errors

• Medication review

• Medication safety

• Medication Safety- Faculty

• MedicialCondition

• Medicine Specific Issues

• Medicines

• Medicines administration

• Medicines and Healthcare products Regulatory Agency (MHRA)

• Medicines counter assistant

• Medicines legislation

• Medicines licensing

• Medicines management

• Medicines optimisation

• Medicines procurement

• Medicines Procurement - Faculty

• Medicines procurement - Foundation

• Medicines reconciliation

• Medicines regulation and law

• Medicines shortages

• Medicines use review

• Menstruation-inducing agents

• Mental health conditions

• Mentoring

• Meta-analysis

• Mexico

• Middle East and North Africa

• Military pharmacy

• Minor ailments

• Modified-release preparations

• Molecular biology

• Monitor

• Monitoring Medicine Therapy

• Multi-compartment compliance aids

• Multiple pharmacy

• Musculoskeletal diseases

• Mycobacterial infections

• Nanotechnology

• Narcotic antagonists

• Nasal decongestants

• National Institute for Health and Care Excellence

• National Pharmacy Association

• National pharmacy contracts

• Natriuretic agents

• Need for the Medicine

• Neonatal and Paediatric Care

• Neonatal and Paediatric Care- Faculty

• Nervous system diseases

• Neurological conditions

• Neuroprotective agents

• New medicine service

• New Zealand

• NGOs

• NHS

• NHS boards (Scotland)

• NHS commissioning and funding

• NHS constitution

• NHS Education for Scotland

• NHS England

• NHS reforms

• NHS trusts

• Nitric oxide donors

• Non-medical prescribing

• Non-prescription medicines

• Nootropic agents

• North America

• Northern Ireland

• NSAIDS - Non-Steroidal anti-inflammatory agents

• Nursing

• Nutritional and metabolic diseases

• Obesity

• Observational studies

• Occupational diseases

• Occupational health

• Oceania

• Ointments

• Ophthalmic solutions

• Opiate substitution therapy

• Opioid analgesics

• Oral liquid preparations

• Organisation

• Organisations - Foundation

• Organization

• Orphan drugs

• Osteoporosis

• Over-the-counter medicines

• Oxytocics

• Paediatrics

• Pain management

• Palliative care

• Palliative care- Faculty

• Parasitic diseases

• Parenteral nutrition solutions

• Parkinson's disease

• Partnership working

• Patents

• Patient access schemes

• Patient confidentiality

• Patient consultation

• Patient group direction

• Patient records

• Patient rights and advocacy

• Patient safety

• Patients

• Pay

• Payment by results

• PDA Union

• Peer review

• Pensions

• People

• Performance review

• Performing research

• Person-centred care

• Personal and professional development

• PersonRoles

• Pharmaceutical care

• Pharmaceutical chemistry

• Pharmaceutical companies

• Pharmaceutical compounding and extemporaneous preparation

• Pharmaceutical industry

• Pharmaceutical preparations

• Pharmaceutical sciences

• Pharmaceutical scientist

• Pharmaceutical Services Negotiating Committee

• Pharmaceutical solutions

• Pharmaceutics

• Pharmacist

• Pharmacist Support

• Pharmacist-led clinic

• Pharmacists' Defence Association

• Pharmacodynamics

• Pharmacoepidemiology

• Pharmacogenetics and pharmacogenomics

• Pharmacognosy and herbal medicine

• Pharmacokinetics

• Pharmacological phenomena

• Pharmacology

• Pharmacotherapy

• Pharmacovigilance

• Pharmacy

• Pharmacy automation

• Pharmacy board elections

• Pharmacy bodies

• Pharmacy business

• Pharmacy practice

• Pharmacy Research UK

• Pharmacy sectors

• Pharmacy specialist groups

• Pharmacy technician

• Pharmacy Voice

• Phase I research

• Phase II research

• Phase III research

• Phase IV research

• Philosophy

• Photosensitising sgents

• Physical and earth sciences

• Physiology

• Pilot projects

• Place

• Placebos

• Platelet aggregation inhibitors

• Poisoning

• Policy and politics

• Politics

• Polypharmacy

• POM-to-P switching

• Postdoctorate student

• Postgraduate student

• Potassium channel blockers

• Poverty

• Powders

• Pre-clinical development

• Pre-clinical research

• Pregnancy, obstetrics, breastfeeding, gynaecology

• Premises regulation

• Preregistration trainee

• Prescribing

• Prescription-only medicines

• Presentation skills

• Primary care

• Private medicine

• Prodrugs

• Professional behaviour

• Professional judgement

• Professional judgement in pharmacy

• Professional knowledge and skills

• Professionalism

• ProfessionalService

• Professions

• Prognosis

• Prophylaxis

• Providing education and training

• Providing Information

• Provision of Medicine

• Psoriasis

• Psychology

• Psychotropic drugs

• PT. Competences for preregistration tutors

• PT1. Being a role model

• PT1a. Working to high professional and ethical standards

• PT1b. Maintaining a patient-centred focus

• PT1c. Maintaining a broad perspective; keeping abreast of professional and wider healthcare issues

• PT1d. Reflecting on performance and undertaking professional development

• PT1e. Managing time and prioritising

• PT2. Being a people manager

• PT2a. Communicating at all levels

• PT2b. Treating all team members with respect

• PT2c. Engendering common purpose amongst the work team

• PT2d. Utilising the skills and knowledge of others

• PT3. Being a trainer and coach

• PT3a. Supporting and advising others in their development

• PT3b. Empowering others to take responsibility for their own learning

• PT3c. Setting objectives with learners and planning training

• PT3d. Creating and using coaching opportunities

• PT3e. Taking account of learners’ needs and learning styles

• PT3f. Encouraging self-appraisal

• PT3g. Providing feedback

• PT4. Being an assessor

• PT4a. Providing learners with opportunities to demonstrate their competence

• PT4b. Assessing diverse sources of evidence

• PT4c. Reviewing progress

• Public health

• Public health England

• Publishing

• Pulmonary surfactants

• Quality control and quality assurance

• Radiation-sensitising agents

• Randomised controlled trials

• Recruitment

• Rectal preparations

• Red Cross

• Registration assessment

• Regulation in healthcare

• Regulators

• Religion

• Renal - Faculty

• Renal agents

• Renal care

• Renal Pharmacy Group

• Reproductive control agents

• Reproductive rights

• Republic of Ireland

• Research and evaluation

• Research and Evaluation - Foundation

• Research design

• Respiratory system agents

• Respiratory tract diseases

• Responsible pharmacist

• Retired pharmacist

• Revalidation

• Rheumatoid arthritis

• Right to die

• Royal College of General Practitioners

• Royal College of Physicians

• Royal Pharmaceutical Society (RPS)

• Royal Society for Public Health

• Royal Society Of Chemistry

• RPS Faculty

• RPS Faculty APF

• RPS Faculty assessment

• RPS Faculty fellow

• RPS Faculty member

• RPS Foundation Programme

• Safety warnings

• Salary

• Schizophrenia

• Science

• Sclerosing solutions

• Scotland

• Scottish Intercollegiate Guidelines Network

• Scottish Medicines Consortium

• Selection of the Medicine

• Self administration

• Self care

• Self-selection of P medicines

• Service development

• Service provision

• Service Provision - Foundation

• Sexually transmitted disease

• Smoking cessation

• Social care

• Social change

• Social justice

• Social networking

• Social sciences and humanities

• Social welfare

• Societies and royal colleges

• Society, law and politics

• Sociology

• Sodium channel blockers

• South America

• Speaking up about concerns

• Specials

• Sports medicine

• Staff Management

• Statins

• Statistics

• Student

• Substance misuse - Faculty

• Substance-related disorders

• Superintendent pharmacist

• Supplementary prescribing

• Supply chain

• Supply issues

• Suppositories

• Surgery

• Systematic review

• Tablets

• Talking therapies

• Taxonomy

• Teamwork

• Technology appraisals

• The Royal Society

• Therapeutic intervention

• TherapeuticProcedure

• Thing

• Tocolytic Agents

• Toxicology

• Tramadol

• Transfer of care

• Transplantation

• Transportation

• Transporter protein

• Tuberculosis - TB

• UK healthcare

• ulcerative colitis

• Undergraduate student

• United Kingdom

• United Kingdom Clinical Pharmacy Association

• United Nations

• United States of America

• Universities

• Unlicensed and off-label medicines

• Urgent and emergency care

• Uricosuric agents

• Urinary anti-infective agents

• Urogenital diseases

• Urological agents

• US Food and Drug Administration (FDA)

• Vaccination

• Vaginal preparations

• Value assessment

• Vasoconstrictor agents

• Vasodilator agents

• Venous thromboembolism

• Veterinary pharmacy

• Viral infections

• Vocational education

• Wales

• Webinar

• Wet age-related macular degeneration

• Wholesaling

• Womens health

• Workforce

• World Health Organization (WHO)

• Wounds burns and injuries